{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5bbce70b05777cdc119a4a4a/5e8f17b1b9fdc9cb7c83d65c?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"COVID-19 and Drug Therapies","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5bbce70b05777cdc119a4a4a/1586458654954-a814a68867c3145014ed70814361f894.jpeg?height=200","description":"<p><a href=\"https://michr.umich.edu/michr-people/2019/2/18/jonathan-sexton\" rel=\"noopener noreferrer\" target=\"_blank\">Jonathan Sexton</a>, U-M Center for Drug Repurposing lead and assistant professor of Internal Medicine at Michigan Medicine, explains how UM-CDR quickly reacted to the coronavirus outbreak and rapidly began identifying and screening drugs that could be effective as therapeutic interventions for COVID-19.</p>","author_name":"University of Michigan"}